CERo Therapeutics Stock (NASDAQ:CERO)
Previous Close
$0.96
52W Range
$0.93 - $376.00
50D Avg
$2.30
200D Avg
$16.08
Market Cap
$3.09M
Avg Vol (3M)
$760.15K
Beta
0.43
Div Yield
-
CERO Company Profile
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.